Ultragenyx appoints independent director
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Ultragenyx Pharmaceutical Inc. appointed Deborah Dunsire to the company's board of directors.
Dunsire, currently president and CEO of XTuit Pharmaceuticals Inc., will serve as an independent director on Ultragenyx's board.
